VivoSeq
Cardiovascular

Cardiac Arrhythmia

24

Pipeline Programs↗

0

Active Trials↗

14

Companies Involved↗

Cardiac Arrhythmia is an emerging landscape with 24 programs across 14 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, AbbVie, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.. 17 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

0/100

Mech. Concentration

13/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Vitae Pharmaceuticals Inc., an Allergan affiliate

1 program

Phase 2AbbVie logo

AbbVie

1 program

ApprovedM

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

1 program

ApprovedA

Arbor Pharmaceuticals, Inc.

1 program

ApprovedBoehringer Ingelheim logo

Boehringer Ingelheim

1 program

ApprovedF

Fresenius Kabi Oncology Ltd.

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed6 · 86%
Unknown status1 · 14%

Clinical Trials

Trial Activity

7 trials

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
Completed·HHospital Clinic of Barcelona·Phase 4·NCT00702117·123 enrolled
Cardiac Arrhythmia Suppression Trial (CAST)
Completed·National Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00000526
Cardiac Arrhythmia Pilot Study (CAPS)
Completed·National Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00000504
Evaluation of Cardiac Arrhythmias in Hand Surgery Using Local Anesthesia With Adrenaline
Completed·—·N/A·NCT04029610·110 enrolled
Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method
Completed·MMedical University of Warsaw·Phase 4·NCT02988219·50 enrolled
A Study of Caffeine on Cardiac Arrhythmias
Completed·OOttawa Heart Institute Research Corporation·N/A·NCT02095405·160 enrolled
Prevention of Post-Operative Cardiac Arrhythmias
Unknown status·—·Phase 4·NCT04234906·870 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)